{
    "nct_id": "NCT05291871",
    "official_title": "Immunogenicity of Fractional Dose of the HPV Vaccines",
    "inclusion_criteria": "* Age 27-45 years at enrollment\n* Not intending to receive the HPV vaccine series for the duration of the study participation\n* Willing and able to: provide written informed consent, undergo clinical evaluation, adhere to follow-up schedule\nHealthy volunteers allowed\nMust have minimum age of 27 Years\nMust have maximum age of 45 Years",
    "exclusion_criteria": "* Prior immunization with HPV-vaccine (Cervarix, Gardasil-4, Gardasil-9)\n* Currently pregnant or breastfeeding\n* Immunedeficiency disease/condition or cancer that causes clinically significant immunosuppression\n* Known HIV infection\n* Chemotherapy (current or within 12 months) or currently taking a medication that causes clinically significant immunosuppression.\n* Unstable medical condition (e.g., malignant hypertension, poorly controlled diabetes)\n* Known allergy to vaccine components\n* Prior history of HPV-associated cancer\n* Any medical condition which, in the opinion of the investigator, may compromise the subject's ability to safely complete the study.",
    "miscellaneous_criteria": ""
}